chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Lymph node pain, Lymphadenopathy
Clinical narrative: Swelling; slight pain in left armpit; This is a spontaneous report from a contactable consumer (Patient herself). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER8734), via an unspecified route of administration, administered in Arm Left on 28Apr2021 14:45 as dose 2, single for COVID-19 immunisation (Age at Vaccination was 34 Years). The patient medical history was none. The patient concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER2613), via an unspecified route of administration, administered in Arm Left on 07Apr2021 15:00 as dose 1, single for COVID-19 immunisation (Age at Vaccination was 34 Years) and experienced Minor discomfort in same spot after first dose, but no swelling, only last one day. It was stated that, the patient was not a pregnant at the time of vaccination. She did not receive any other vaccine in four weeks prior COVID vaccination. She was not diagnosed with COVID prior vaccination and not been tested with COVID post vaccination. She had no known allergies. On 30Apr2021, the patient experienced swelling and slight pain in left armpit (started two days later, worse on third day). No therapeutic measures were taken as a result of events. The outcome of the events was recovering.    No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: Swelling; slight pain in left armpit; This is a spontaneous report from a contactable consumer (Patient herself). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER8734), via an unspecified route of administration, administered in Arm Left on 28Apr2021 14:45 as dose 2, single for COVID-19 immunisation (Age at Vaccination was 34 Years). The patient medical history was none. The patient concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER2613), via an unspecified route of administration, administered in Arm Left on 07Apr2021 15:00 as dose 1, single for COVID-19 immunisation (Age at Vaccination was 34 Years) and experienced Minor discomfort in same spot after first dose, but no swelling, only last one day. It was stated that, the patient was not a pregnant at the time of vaccination. She did not receive any other vaccine in four weeks prior COVID vaccination. She was not diagnosed with COVID prior vaccination and not been tested with COVID post vaccination. She had no known allergies. On 30Apr2021, the patient experienced swelling and slight pain in left armpit (started two days later, worse on third day). No therapeutic measures were taken as a result of events. The outcome of the events was recovering.    No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site bruising
Clinical narrative: she experienced rashes; her arm (site of injection) turned black and blue in color; This is a spontaneous report from a Pfizer Sponsored Program  via contactable consumer (reported for herself). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 17Apr2021 as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 27Mar2021 as dose 1, single for COVID-19 immunization. On an unspecified date in 2021, the patient experienced rashes and arm (site of injection) turned black and blue in color. The patient was reporting that she experienced rashes and her arm (site of injection) turned black and blue in color after she received the 2nd dose of Covid 19 vaccine last 17Apr2021. She was asking if these symptoms were normal. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Vaccination site discolouration
Clinical narrative: she experienced rashes; her arm (site of injection) turned black and blue in color; This is a spontaneous report from a Pfizer Sponsored Program  via contactable consumer (reported for herself). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 17Apr2021 as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 27Mar2021 as dose 1, single for COVID-19 immunization. On an unspecified date in 2021, the patient experienced rashes and arm (site of injection) turned black and blue in color. The patient was reporting that she experienced rashes and her arm (site of injection) turned black and blue in color after she received the 2nd dose of Covid 19 vaccine last 17Apr2021. She was asking if these symptoms were normal. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was underaged
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was underaged for the vaccine at the time of administration
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19 pneumonia, Chills, Confusional state, Decreased appetite
Clinical narrative: Patient was fully vaccinated for COVID-19 and died from complications post-COVID infection.  Pfizer vaccine dose #1 was on 1/29/2021 Pfizer vaccine dose #2 was on 2/24/2021  Patient tested positive for COVID-19 via PCR on 6/18/2021 Patient died from COVID-19 on 10/5/2021
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mental impairment, Pain, Respiratory tract congestion
Clinical narrative: Patient was fully vaccinated for COVID-19 and died from complications post-COVID infection.  Pfizer vaccine dose #1 was on 1/29/2021 Pfizer vaccine dose #2 was on 2/24/2021  Patient tested positive for COVID-19 via PCR on 6/18/2021 Patient died from COVID-19 on 10/5/2021
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient was fully vaccinated for COVID-19 and died from complications post-COVID infection.  Pfizer vaccine dose #1 was on 1/29/2021 Pfizer vaccine dose #2 was on 2/24/2021  Patient tested positive for COVID-19 via PCR on 6/18/2021 Patient died from COVID-19 on 10/5/2021
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema, Dyspnoea, Throat tightness
Clinical narrative: Within 2 hours of the injection my eyes started to burn and itch terribly.  Then my face swelled, my throat started to close and I had trouble breathing.  I took Benadryl as soon as my throat started to close.  I continued to take Benadryl through out the night. My throat felt better and my breathing returned to normal after the Benadryl took affect.  In the morning my face was so swollen it was hard to see so I went to the Urgent Care.  Once I was in and examined they told me I had to go to the ER.  My husband took me to the ER where I was treated for Angio-edema.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Eye irritation, Eye pruritus, Swelling face, Throat tightness
Clinical narrative: Within 2 hours of the injection my eyes started to burn and itch terribly.  Then my face swelled, my throat started to close and I had trouble breathing.  I took Benadryl as soon as my throat started to close.  I continued to take Benadryl through out the night. My throat felt better and my breathing returned to normal after the Benadryl took affect.  In the morning my face was so swollen it was hard to see so I went to the Urgent Care.  Once I was in and examined they told me I had to go to the ER.  My husband took me to the ER where I was treated for Angio-edema.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Confusional state, Decreased appetite, Dizziness, Fall, Fatigue
Clinical narrative: Ataxia, encephalitis.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Impaired self-care, Magnetic resonance imaging abnormal, Nausea
Clinical narrative: Ataxia, encephalitis.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Death, Immune-mediated encephalitis, Neurological symptom, Vaccine associated enhanced disease
Clinical narrative: Ataxia, encephalitis.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Ataxia, Encephalitis
Clinical narrative: Ataxia, encephalitis.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood alkaline phosphatase increased, Blood creatine phosphokinase decreased, C-reactive protein normal, Differential white blood cell count, Erythema
Clinical narrative: Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; This is a spontaneous report from a contactable consumer. A 12-year-old non pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: FC3181) via an unspecified route of administration on 19Aug2021 (at the age of 12 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included FLUOXETINE taken for an unspecified indication, start and stop date were not reported. She received fluoxetine 30mg within 2 weeks of vaccination. The patient previously took first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: EW0781) via an unspecified route of administration on 29Jul2021 as dose 1, single for covid-19 immunisation; it was reported drug as none and experienced allergy. She did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination She was not diagnosed with COVID-19. Since the vaccination she had tested positive for COVID-19. On 05Nov2021, the patient experienced patient had breakthrough case, tested positive for covid-19. The patient underwent lab tests and procedures which included Nasal Swab positive Nasal Swab on 05Nov2021. She did not receive any treatment for adverse events. The clinical outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count normal, Immediate post-injection reaction, Loss of personal independence in daily activities, Metabolic function test, Myalgia
Clinical narrative: Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; This is a spontaneous report from a contactable consumer. A 12-year-old non pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: FC3181) via an unspecified route of administration on 19Aug2021 (at the age of 12 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included FLUOXETINE taken for an unspecified indication, start and stop date were not reported. She received fluoxetine 30mg within 2 weeks of vaccination. The patient previously took first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: EW0781) via an unspecified route of administration on 29Jul2021 as dose 1, single for covid-19 immunisation; it was reported drug as none and experienced allergy. She did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination She was not diagnosed with COVID-19. Since the vaccination she had tested positive for COVID-19. On 05Nov2021, the patient experienced patient had breakthrough case, tested positive for covid-19. The patient underwent lab tests and procedures which included Nasal Swab positive Nasal Swab on 05Nov2021. She did not receive any treatment for adverse events. The clinical outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia, Urine analysis
Clinical narrative: Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; This is a spontaneous report from a contactable consumer. A 12-year-old non pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: FC3181) via an unspecified route of administration on 19Aug2021 (at the age of 12 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included FLUOXETINE taken for an unspecified indication, start and stop date were not reported. She received fluoxetine 30mg within 2 weeks of vaccination. The patient previously took first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: EW0781) via an unspecified route of administration on 29Jul2021 as dose 1, single for covid-19 immunisation; it was reported drug as none and experienced allergy. She did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination She was not diagnosed with COVID-19. Since the vaccination she had tested positive for COVID-19. On 05Nov2021, the patient experienced patient had breakthrough case, tested positive for covid-19. The patient underwent lab tests and procedures which included Nasal Swab positive Nasal Swab on 05Nov2021. She did not receive any treatment for adverse events. The clinical outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccination failure
Clinical narrative: Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; Patient had breakthrough case, tested positive for covid-19 on 05Nov2021; This is a spontaneous report from a contactable consumer. A 12-year-old non pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: FC3181) via an unspecified route of administration on 19Aug2021 (at the age of 12 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included FLUOXETINE taken for an unspecified indication, start and stop date were not reported. She received fluoxetine 30mg within 2 weeks of vaccination. The patient previously took first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Batch/Lot Number: EW0781) via an unspecified route of administration on 29Jul2021 as dose 1, single for covid-19 immunisation; it was reported drug as none and experienced allergy. She did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination She was not diagnosed with COVID-19. Since the vaccination she had tested positive for COVID-19. On 05Nov2021, the patient experienced patient had breakthrough case, tested positive for covid-19. The patient underwent lab tests and procedures which included Nasal Swab positive Nasal Swab on 05Nov2021. She did not receive any treatment for adverse events. The clinical outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood magnesium normal, Blood thyroid stimulating hormone normal, Computerised tomogram head normal, Electrocardiogram normal, Extra dose administered
Clinical narrative: Several hours after receiving my booster vaccination and I began to feel ill. I could not sleep, had chills, and a stomach ache. I got out of bed to go to the bathroom and began to feel like I was going to throw up. I sat on the floor. Later my husband woke up and said it appeared that I was having a seizure. It took me several minutes to come to and then after coming to, another several minutes to understand what had happened. The after hours nurse we called told me to go straight to the ER.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer normal, Full blood count normal, Human chorionic gonadotropin normal, Immunosuppression, Influenza like illness
Clinical narrative: Several hours after receiving my booster vaccination and I began to feel ill. I could not sleep, had chills, and a stomach ache. I got out of bed to go to the bathroom and began to feel like I was going to throw up. I sat on the floor. Later my husband woke up and said it appeared that I was having a seizure. It took me several minutes to come to and then after coming to, another several minutes to understand what had happened. The after hours nurse we called told me to go straight to the ER.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Myalgia, SARS-CoV-2 test negative, Syncope, Troponin normal
Clinical narrative: Several hours after receiving my booster vaccination and I began to feel ill. I could not sleep, had chills, and a stomach ache. I got out of bed to go to the bathroom and began to feel like I was going to throw up. I sat on the floor. Later my husband woke up and said it appeared that I was having a seizure. It took me several minutes to come to and then after coming to, another several minutes to understand what had happened. The after hours nurse we called told me to go straight to the ER.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chills, Electrocardiogram, Electroencephalogram, Insomnia
Clinical narrative: Several hours after receiving my booster vaccination and I began to feel ill. I could not sleep, had chills, and a stomach ache. I got out of bed to go to the bathroom and began to feel like I was going to throw up. I sat on the floor. Later my husband woke up and said it appeared that I was having a seizure. It took me several minutes to come to and then after coming to, another several minutes to understand what had happened. The after hours nurse we called told me to go straight to the ER.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Malaise, Seizure
Clinical narrative: Several hours after receiving my booster vaccination and I began to feel ill. I could not sleep, had chills, and a stomach ache. I got out of bed to go to the bathroom and began to feel like I was going to throw up. I sat on the floor. Later my husband woke up and said it appeared that I was having a seizure. It took me several minutes to come to and then after coming to, another several minutes to understand what had happened. The after hours nurse we called told me to go straight to the ER.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Epistaxis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: unknown; Expiration Date: Unknown) via an unspecified route of administration, administered in Arm Left on 08Apr2021 12:15 (at the age of 46-year-old) as dose 2, single for covid-19 immunization. Medical history included Diabetes type 2, high blood pressure. The patient received medications for Blood pressure and diabetic meds within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19, since the vaccination. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: unknown; Expiration Date: Unknown) via an unspecified route of administration on 18Mar2021 01:00 PM (at the age of 46-year-old), as dose 1, single for covid-19 immunization. The patient experienced almost daily bloody nose since 10Apr2021. The patient did not receive any treatment for AE. The clinical outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Central Retinal Vein Thrombosis; This is a spontaneous report from contactable physician (patient). A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: EP6955) via an unspecified route of administration on 24Mar2021 (at the age of 63-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications (received within 2 weeks of vaccination) included atorvastatin taken for an unspecified indication on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: EL3247) via an unspecified route of administration on 03Mar2021 (at the age of 63-years-old) as a single dose in the left arm for COVID-19 immunization. On 02Nov2021, the patient experienced central retinal vein thrombosis. The event was reported as non-serious. The event did not result in hospitalization or hospitalization prolonged. The event resulted in a doctor or other healthcare professional office/clinic visit. Treatment was not received for the event. The clinical outcome of the event central retinal vein thrombosis was unknown. Since the vaccination, the patient had not been tested for COVID-19.   Follow-up attempts are completed. No further information is expected. Sender's Comments: The event retinal vein thrombosis most likely considered as intercurrent condition and unrelated to suspect product BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE). This case will be reassessed upon receipt of follow-up information.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Retinal vein thrombosis
Clinical narrative: Central Retinal Vein Thrombosis; This is a spontaneous report from contactable physician (patient). A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: EP6955) via an unspecified route of administration on 24Mar2021 (at the age of 63-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications (received within 2 weeks of vaccination) included atorvastatin taken for an unspecified indication on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: EL3247) via an unspecified route of administration on 03Mar2021 (at the age of 63-years-old) as a single dose in the left arm for COVID-19 immunization. On 02Nov2021, the patient experienced central retinal vein thrombosis. The event was reported as non-serious. The event did not result in hospitalization or hospitalization prolonged. The event resulted in a doctor or other healthcare professional office/clinic visit. Treatment was not received for the event. The clinical outcome of the event central retinal vein thrombosis was unknown. Since the vaccination, the patient had not been tested for COVID-19.   Follow-up attempts are completed. No further information is expected. Sender's Comments: The event retinal vein thrombosis most likely considered as intercurrent condition and unrelated to suspect product BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE). This case will be reassessed upon receipt of follow-up information.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Haemoglobin decreased, Haemorrhage, Oesophagogastroduodenoscopy normal, Thrombocytopenia
Clinical narrative: The pt received the vaccine Sept 1st, 2021. On Sept 8th, 2021, the pt developed mesenteric clots in his GI tract. The pt was  hospitalized at a local Hospital.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Transfusion
Clinical narrative: The pt received the vaccine Sept 1st, 2021. On Sept 8th, 2021, the pt developed mesenteric clots in his GI tract. The pt was  hospitalized at a local Hospital.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Coagulation test, Full blood count, Mesenteric vein thrombosis, Metabolic function test
Clinical narrative: The pt received the vaccine Sept 1st, 2021. On Sept 8th, 2021, the pt developed mesenteric clots in his GI tract. The pt was  hospitalized at a local Hospital.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Caller also states that after each dose of the Pfizer Covid 19 Vaccine he experienced a metallic taste; high blood pressure; fevers; Chest pain; Headache; Was given dose of the Pfizer Covid 19 Vaccine instead of the Flu Vaccine; Was given dose of the Pfizer Covid 19 Vaccine instead of the Flu Vaccine; Caller mentions later in the call that since the vaccine he has been having arm pain on and off.; This is a spontaneous report from a contactable Consumer reported that: A 35-years-old male patient received third dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on 04Oct2021 (Age at Vaccination 35-years-old) as DOSE 3, (BOOSTER DOSE), SINGLE for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. Previously patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW0150) via an unspecified route of administration on 02Apr2021 (Age at Vaccination 34-years-old) as DOSE 2, SINGLE second dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW0164) via an unspecified route of administration on 30Apr2021 (Age at Vaccination 34-years-old) as DOSE 2, SINGLE for COVID-19 immunization. On 04Oct2021The patient experienced was given dose of the pfizer covid 19 vaccine instead of the flu vaccine, caller mentions later in the call that since the vaccine he has been having arm pain on and off. On an unspecified date caller also states that after each dose of the pfizer covid 19 vaccine he experienced a metallic taste, high blood pressure, fevers, chest pain and headache. The patient underwent lab tests and procedures which included blood pressure measurement: high on unspecified date. The outcome of the events fevers and headache was recovering. While other was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Chest pain, Dysgeusia, Headache, Hypertension
Clinical narrative: Caller also states that after each dose of the Pfizer Covid 19 Vaccine he experienced a metallic taste; high blood pressure; fevers; Chest pain; Headache; Was given dose of the Pfizer Covid 19 Vaccine instead of the Flu Vaccine; Was given dose of the Pfizer Covid 19 Vaccine instead of the Flu Vaccine; Caller mentions later in the call that since the vaccine he has been having arm pain on and off.; This is a spontaneous report from a contactable Consumer reported that: A 35-years-old male patient received third dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on 04Oct2021 (Age at Vaccination 35-years-old) as DOSE 3, (BOOSTER DOSE), SINGLE for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. Previously patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW0150) via an unspecified route of administration on 02Apr2021 (Age at Vaccination 34-years-old) as DOSE 2, SINGLE second dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW0164) via an unspecified route of administration on 30Apr2021 (Age at Vaccination 34-years-old) as DOSE 2, SINGLE for COVID-19 immunization. On 04Oct2021The patient experienced was given dose of the pfizer covid 19 vaccine instead of the flu vaccine, caller mentions later in the call that since the vaccine he has been having arm pain on and off. On an unspecified date caller also states that after each dose of the pfizer covid 19 vaccine he experienced a metallic taste, high blood pressure, fevers, chest pain and headache. The patient underwent lab tests and procedures which included blood pressure measurement: high on unspecified date. The outcome of the events fevers and headache was recovering. While other was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immunisation, Pain in extremity, Pyrexia, Wrong product administered
Clinical narrative: Caller also states that after each dose of the Pfizer Covid 19 Vaccine he experienced a metallic taste; high blood pressure; fevers; Chest pain; Headache; Was given dose of the Pfizer Covid 19 Vaccine instead of the Flu Vaccine; Was given dose of the Pfizer Covid 19 Vaccine instead of the Flu Vaccine; Caller mentions later in the call that since the vaccine he has been having arm pain on and off.; This is a spontaneous report from a contactable Consumer reported that: A 35-years-old male patient received third dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on 04Oct2021 (Age at Vaccination 35-years-old) as DOSE 3, (BOOSTER DOSE), SINGLE for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. Previously patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW0150) via an unspecified route of administration on 02Apr2021 (Age at Vaccination 34-years-old) as DOSE 2, SINGLE second dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW0164) via an unspecified route of administration on 30Apr2021 (Age at Vaccination 34-years-old) as DOSE 2, SINGLE for COVID-19 immunization. On 04Oct2021The patient experienced was given dose of the pfizer covid 19 vaccine instead of the flu vaccine, caller mentions later in the call that since the vaccine he has been having arm pain on and off. On an unspecified date caller also states that after each dose of the pfizer covid 19 vaccine he experienced a metallic taste, high blood pressure, fevers, chest pain and headache. The patient underwent lab tests and procedures which included blood pressure measurement: high on unspecified date. The outcome of the events fevers and headache was recovering. While other was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Cardiac monitoring, Chest pain, Dyspnoea, Electrocardiogram
Clinical narrative: Developed dizziness , shortness of breath, and palpitations  starting  48 hours after second dose of vaccine.  Has also had syncope since then.  Now has daily dizziness, and palpitations.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Tachycardia
Clinical narrative: Developed dizziness , shortness of breath, and palpitations  starting  48 hours after second dose of vaccine.  Has also had syncope since then.  Now has daily dizziness, and palpitations.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Dizziness, Dyspnoea, Echocardiogram, Electrocardiogram
Clinical narrative: Developed dizziness , shortness of breath, and palpitations  starting  48 hours after second dose of vaccine.  Has also had syncope since then.  Now has daily dizziness, and palpitations.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Physical examination normal, Syncope, Troponin
Clinical narrative: Developed dizziness , shortness of breath, and palpitations  starting  48 hours after second dose of vaccine.  Has also had syncope since then.  Now has daily dizziness, and palpitations.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blister, Herpes zoster, Pain of skin, Sensitive skin, Skin lesion
Clinical narrative: Wide area of extreme skin sensitivity; This was followed by large areas of an acute shingles outbreak with blistering.; This was followed by large areas of an acute shingles outbreak with blistering.; This is a spontaneous report from a contactable consumer or other non hcp. A 55-year-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: FF2587), via an unspecified route of administration, administered in the left arm on 02Oct2021 14:30 age at the time of vaccination was 55-year-old as dose 1 single for COVID-19 immunisation. The patient's medical history included drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medications included hydrocortisone taken for an unspecified indication, start and stop date were not reported; Armour thyroid taken for an unspecified indication, start and stop date were not reported. The patient had penicillin allergy. On 12Oct2021, the patient experienced wide area of extreme skin sensitivity, this was followed by large areas of an acute shingles outbreak with blistering. The patient underwent lab tests and procedures which included sars-cov-2 test result was negative on 15Oct2021. Treatment medication included Valacyclovir were taken as a result of wide area of extreme skin sensitivity, this was followed by large areas of an acute shingles outbreak with blistering. The outcome of wide area of extreme skin sensitivity, this was followed by large areas of an acute shingles outbreak with blistering was not recovered  Follow-up attempts are completed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blister, Herpes zoster, SARS-CoV-2 test, Sensitive skin
Clinical narrative: Wide area of extreme skin sensitivity; This was followed by large areas of an acute shingles outbreak with blistering.; This was followed by large areas of an acute shingles outbreak with blistering.; This is a spontaneous report from a contactable consumer or other non hcp. A 55-year-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: FF2587), via an unspecified route of administration, administered in the left arm on 02Oct2021 14:30 age at the time of vaccination was 55-year-old as dose 1 single for COVID-19 immunisation. The patient's medical history included drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medications included hydrocortisone taken for an unspecified indication, start and stop date were not reported; Armour thyroid taken for an unspecified indication, start and stop date were not reported. The patient had penicillin allergy. On 12Oct2021, the patient experienced wide area of extreme skin sensitivity, this was followed by large areas of an acute shingles outbreak with blistering. The patient underwent lab tests and procedures which included sars-cov-2 test result was negative on 15Oct2021. Treatment medication included Valacyclovir were taken as a result of wide area of extreme skin sensitivity, this was followed by large areas of an acute shingles outbreak with blistering. The outcome of wide area of extreme skin sensitivity, this was followed by large areas of an acute shingles outbreak with blistering was not recovered  Follow-up attempts are completed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aggression, COVID-19 pneumonia, Cognitive disorder, Confusional state, Encephalopathy
Clinical narrative: Emergency Department as a medical resuscitation activation for presumed seizure found to be COVID positive.  While here he is found to be hemodynamically stable, requiring supplemental oxygen (2 L) for hypoxia.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Hypoxia, Resuscitation, SARS-CoV-2 test positive, Seizure
Clinical narrative: Emergency Department as a medical resuscitation activation for presumed seizure found to be COVID positive.  While here he is found to be hemodynamically stable, requiring supplemental oxygen (2 L) for hypoxia.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Product preparation issue
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Injection site pain, Joint swelling, Nausea, Pain in extremity
Clinical narrative: bleeding perforated ulcers in my stomach; eyes became blurry; left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm; left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm; chest pains at night; veins was popped up in (left) arm; wake up gasping for air; not sleeping; stomach pains; This is a spontaneous report from a contactable consumer. This 63-year-old female consumer (patient) reported that: A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 63 years) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history included chronic obstructive pulmonary disease (COPD) because she had smoked since she was 16. The patient was not sleeping before she got the shot. It was all reported on an unspecified date. The patient's concomitant medications included steroid inhalers for COPD. She was a pretty healthy girl. She drinks turmeric tea every day. On an unspecified date, bleeding perforated ulcers in my stomach, eyes became blurry, left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm, chest pains at night, veins was popped up in (left) arm, wake up gasping for air, not sleeping and stomach pains. It was reported that, the patient stated that she received her first dose of the Pfizer COVID-19 vaccine, and reported the following: (soon after the shot) the patient stated her eyes became blurry and then she goes out to her truck after about 25 minutes and her left arm became swollen with 2 red lines (redness) going up her arm which doesn't even make sense because she got the shot in her right arm. The patient also stated she had bleeding perforated ulcers in her stomach, chest pains at night, her veins were popped up in her left arm and she was not sleeping. She woke up gasping for air because of the chest pains and the stomach pains that are not subsiding. She didn't do that before all of this. She was made to get this vaccine or else she was going to lose her job of 40 years. The patient also stated she wasn't sleeping before she got the shot because of this stupid mandate. She had so much anxiety over this second shot because she was terrified something is going to happen to her. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Rash erythematous, Vision blurred
Clinical narrative: bleeding perforated ulcers in my stomach; eyes became blurry; left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm; left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm; chest pains at night; veins was popped up in (left) arm; wake up gasping for air; not sleeping; stomach pains; This is a spontaneous report from a contactable consumer. This 63-year-old female consumer (patient) reported that: A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 63 years) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history included chronic obstructive pulmonary disease (COPD) because she had smoked since she was 16. The patient was not sleeping before she got the shot. It was all reported on an unspecified date. The patient's concomitant medications included steroid inhalers for COPD. She was a pretty healthy girl. She drinks turmeric tea every day. On an unspecified date, bleeding perforated ulcers in my stomach, eyes became blurry, left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm, chest pains at night, veins was popped up in (left) arm, wake up gasping for air, not sleeping and stomach pains. It was reported that, the patient stated that she received her first dose of the Pfizer COVID-19 vaccine, and reported the following: (soon after the shot) the patient stated her eyes became blurry and then she goes out to her truck after about 25 minutes and her left arm became swollen with 2 red lines (redness) going up her arm which doesn't even make sense because she got the shot in her right arm. The patient also stated she had bleeding perforated ulcers in her stomach, chest pains at night, her veins were popped up in her left arm and she was not sleeping. She woke up gasping for air because of the chest pains and the stomach pains that are not subsiding. She didn't do that before all of this. She was made to get this vaccine or else she was going to lose her job of 40 years. The patient also stated she wasn't sleeping before she got the shot because of this stupid mandate. She had so much anxiety over this second shot because she was terrified something is going to happen to her. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chest pain, Dyspnoea, Erythema, Insomnia
Clinical narrative: bleeding perforated ulcers in my stomach; eyes became blurry; left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm; left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm; chest pains at night; veins was popped up in (left) arm; wake up gasping for air; not sleeping; stomach pains; This is a spontaneous report from a contactable consumer. This 63-year-old female consumer (patient) reported that: A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 63 years) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history included chronic obstructive pulmonary disease (COPD) because she had smoked since she was 16. The patient was not sleeping before she got the shot. It was all reported on an unspecified date. The patient's concomitant medications included steroid inhalers for COPD. She was a pretty healthy girl. She drinks turmeric tea every day. On an unspecified date, bleeding perforated ulcers in my stomach, eyes became blurry, left arm became swollen with 2 red lines going up arm, the swelling was in left arm and got the shot in right arm, chest pains at night, veins was popped up in (left) arm, wake up gasping for air, not sleeping and stomach pains. It was reported that, the patient stated that she received her first dose of the Pfizer COVID-19 vaccine, and reported the following: (soon after the shot) the patient stated her eyes became blurry and then she goes out to her truck after about 25 minutes and her left arm became swollen with 2 red lines (redness) going up her arm which doesn't even make sense because she got the shot in her right arm. The patient also stated she had bleeding perforated ulcers in her stomach, chest pains at night, her veins were popped up in her left arm and she was not sleeping. She woke up gasping for air because of the chest pains and the stomach pains that are not subsiding. She didn't do that before all of this. She was made to get this vaccine or else she was going to lose her job of 40 years. The patient also stated she wasn't sleeping before she got the shot because of this stupid mandate. She had so much anxiety over this second shot because she was terrified something is going to happen to her. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.